These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080 [TBL] [Abstract][Full Text] [Related]
13. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi. Wrightsman RA; Manning JE Vaccine; 2000 Jan; 18(14):1419-27. PubMed ID: 10618540 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice. Gupta S; Garg NJ PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586 [TBL] [Abstract][Full Text] [Related]
15. The Driving of Immune Response by Th1 Adjuvants in Immunization of Mice with Trypanosoma cruzi marinkellei Elicits a Controversial Infection Control. Nascentes GA; Hernández CG; Rabelo RA; Coelho RF; Morais FR; Marques T; Batista LR; Meira WS; Oliveira CJ; Lages Silva E; Ramírez LE Vector Borne Zoonotic Dis; 2016 May; 16(5):317-25. PubMed ID: 26959861 [TBL] [Abstract][Full Text] [Related]
16. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease. Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192 [TBL] [Abstract][Full Text] [Related]
17. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554 [TBL] [Abstract][Full Text] [Related]